A heartfelt message, estrogen replacement therapy: use it or lose it

Area of Science:

• Reproductive Endocrinology
• Cardiovascular Health
• Neuroscience

Background:

• Women experience lower cardiovascular disease risk premenopausally compared to men.
• Postmenopause increases women's risk for cardiovascular disease, cognitive decline, and dementia.
• Estrogen loss is a key difference between pre- and postmenopausal women.

Purpose of the Study:

• To review the historical, current, and future perspectives on menopausal hormone treatment (MHT).
• To re-evaluate the benefit-to-risk ratio of MHT based on the "timing hypothesis".

Main Methods:

• Review of historical data and clinical trials on MHT.
• Reappraisal of a major randomized clinical trial.
• Discussion of the "critical window" or "timing hypothesis" for MHT.

Main Results:

• Initial MHT studies showed promise but were later refuted by a major trial.
• The "timing hypothesis" suggests MHT benefits depend on initiation time relative to menopause.
• This reappraisal offers a new perspective on MHT's benefit-to-risk ratio.

Conclusions:

• The role of MHT in women's cardiovascular and cognitive health is complex and timing-dependent.
• The "critical window" concept reframes MHT's potential benefits and risks.
• Future approaches to MHT should consider the "timing hypothesis" for optimal outcomes.